About this document
Monitoring Drug-Resistant Leprosy Trends by Cynthia Tanuwijoyo is a document available to read on EtoBox.
This document summarizes the current status of drug-resistant leprosy. It discusses the drugs used to treat leprosy, including dapsone, rifampicin and clofazimine, as part of multidrug therapy (MDT). Resistance to dapsone in Mycobacterium leprae is most commonly associated with mutations in the folP1 gene. Resistance to rifampicin involves mutations in the rpoB gene. While MDT has significantly reduced leprosy prevalence globally, ongoing monitoring is needed to detect drug-resistant strains and prevent tre
- Author
- Cynthia Tanuwijoyo
- Language
- EN